Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

KRXAX vs. IXJ: which is better?

Bottom line

KRXAX vs IXJ: the short answer

KRXAX (Kinetics Medical Fund) and IXJ (iShares Global Healthcare ETF) are both mutual funds.

Updated Nov 19, 2026

KRXAX vs IXJ side by side

KRXAXIXJ
TypeMutual fundETF
Fund familyKinetics MutualiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.38%
Annual cost per $10k—$38
10-yr cost on $10k (prospectus)—$480
Max front load—None
12b-1 fee—0%
1-yr return—+14.9%
5-yr return (annualized)—+6.4%
10-yr return (annualized)—+8.2%
Best quarter—+13.6%
Worst quarter—−11.8%
Net assets (fund)—$3.8B
Number of holdings—124
Portfolio turnover—2%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

KRXAX and IXJ share none of their top holdings.

KRXAX top 10

    IXJ top 10

    1. Eli Lilly And Company — 10.93%
    2. Johnson & Johnson — 7.04%
    3. Abbvie Inc. — 5.12%
    4. Unitedhealth Group Incorporated — 4.40%
    5. Merck & Co., Inc. — 4.12%
    6. Astrazeneca Plc — 3.76%
    7. Roche Holding AG — 3.75%
    8. Novartis AG — 3.71%
    9. Amgen Inc. — 2.54%
    10. Thermo Fisher Scientific Incorporated — 2.42%

    FAQ

    What is the difference between KRXAX and IXJ?
    KRXAX (Kinetics Medical Fund) and IXJ (iShares Global Healthcare ETF) are both mutual funds.
    Should I own both KRXAX and IXJ?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.